Kuwait has officially become a member of the global drug regulators’ network, gaining access to specialized international working groups for evaluating modern pharmaceutical preparations. Participation in the program allows Kuwait to benefit from advanced expertise provided by leading global regulatory agencies, enabling the country to enhance its regulatory framework in alignment with the latest healthcare advancements.
Read more from arabtimesonline.com
